title: Discussion: Newer bisphosphonates in the treatment of Paget's disease of bone: where we are and where we want to go.
authors.affiliation: Institute for Endocrinology and Nuclear Medicine, Frankfurt, Germany.
authors.forename: A
authors.initials: A
authors.lastname: Grauer
authors.forename: H
authors.initials: H
authors.lastname: Bone
authors.forename: E V
authors.initials: EV
authors.lastname: McCloskey
authors.forename: M
authors.initials: M
authors.lastname: McClung
authors.forename: D H
authors.initials: DH
authors.lastname: Gutteridge
authors.forename: K W
authors.initials: KW
authors.lastname: Lyles
authors.forename: C
authors.initials: C
authors.lastname: Mautalen
authors.forename: G
authors.initials: G
authors.lastname: Rodan
authors.forename: S
authors.initials: S
authors.lastname: Wallach
mesh_terms: D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy*
chemical_list: D004164:Diphosphonates